Personale docente

Angelo Avogaro

Professore ordinario

MED/13

Indirizzo: VIA GIUSTINIANI, 2 - PADOVA . . .

Telefono: 0498212178

E-mail: angelo.avogaro@unipd.it

  • Il Lunedi' dalle 10:00 alle 11:00


Angelo Avogaro

Professore Ordinario di Endocrinologia e Metabolismo

Responsabile di U.O.C. di Malattie del Metabolismo e servizio aggregato di Diabetologia Azienda Ospedaliera di Padova Specializzazione in Malattie del Ricambio e Medicina Interna

Membro del Review Committee and Programme Board Meeting della
European Foundation for the Study of Diabetes. Membro dell' Editoria! Board di JACC
membro dell'Editorial Board del Journal of Diabetes and its
Complications
Membro dell' Editorial Board di Diabetes Care
Membro dell'Editorial Board di Diabetes, Obesity& Metabolism
Senior Editor di Diabetes & Nutrition
Membro del Consiglio Direttivo della Società Italiana di Endocrinologia
Dal 2001Principallnvestigator in numerosi studi di fase 3 e 4.

Reviewer per le seguenti riviste internazionali:

-Diabetologia, Diabetes, Nutrition and Metabolism, Acta Endocrinologica, Diabetes, European Journal of Clinica lnvestigation, Giornale Italiano di Cardiologia, Drugs, Journal of Endocrinological lnvestigation, Diabetes Care. lnternational Journal of Obesity, American Journal of Physiology, Journal of Hypertension, JACC, Journal of thE Clinica! Endocrinology & Metabolism, Pharmacological Research, Arteriosclerosis Thrombosis and Vascular Biology Kidney lnternational, European Journal of Endocrinology, Circulation, lnternational Journal of Cardiology, lnternational Journal of Cancer
Top reviewer per Diabetes Care 2012

Ho servito come reviewer per le seguenti istituzioni: Diabetes UK,
United States-lsrael Binational Science Foundation
Swiss Research Foundation
Dutch Diabetes research Foundation
European Foundation for the Study of Diabetes

H index Web of Science: 46

Indelicato L, Mariano V, Galasso S, Boscari F, Cipponeri E, Negri C, Frigo A, Avogaro A, Bonora E, Trombetta M, Bruttomesso D. Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy. Diabet Med. 2017 May;34(5):691-697. doi: 10.1111/dme.13321. Epub 2017 Feb 20.

Rigato M, Monami M, Fadini GP. Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies. Circ Res. 2017 Apr 14;120(8):1326-1340. doi: 10.1161/CIRCRESAHA.116.309045. Epub 2017 Jan 17.

Kovatchev B, Cheng P, Anderson SM, Pinsker JE, Boscari F, Buckingham BA, Doyle FJ 3rd, Hood KK, Brown SA, Breton MD, Chernavvsky D, Bevier WC, Bradley PK, Bruttomesso D, Del Favero S, Calore R, Cobelli C, Avogaro A, Ly TT, Shanmugham S, Dassau E, Kollman C, Lum JW, Beck RW. Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery. Diabetes Technol Ther. 2017 Jan;19(1):18-24. doi: 10.1089/dia.2016.0333. Epub 2016 Dec 16.

Scattolini V, Luni C, Zambon A, Galvanin S, Gagliano O, Ciubotaru CD, Avogaro A, Mammano F, Elvassore N, Fadini GP. Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures. Diabetes Ther. 2016 Dec;7(4):679-693. Epub 2016 Nov 9. Erratum in: Diabetes Ther. 2016 Nov 30;: Diabetes Ther. 2017 Feb;8(1):207.

Fadini GP, Rigato M, Cappellari R, Bonora BM, Avogaro A. Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes. Diabetes Care. 2017 Jan;40(1):125-131. doi: 10.2337/dc16-1755. Epub 2016 Nov 4.

Kropff J, DeJong J, Del Favero S, Place J, Messori M, Coestier B, Farret A, Boscari F, Galasso S, Avogaro A, Bruttomesso D, Cobelli C, Renard E, Magni L, DeVries JH; AP@home consortium.. Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial. Diabet Med. 2017
Feb;34(2):262-271. doi: 10.1111/dme.13268. Epub 2016 Oct 28.

Di Nisio A, Rocca MS, Fadini GP, De Toni L, Marcuzzo G, Marescotti MC, Sanna M, Plebani M, Vettor R, Avogaro A, Foresta C. The rs2274911 polymorphism I GPRC6A gene is associated with insulin resistance in normal weight and obese subjects. Clin Endocrinol (Oxf). 2017 Feb;86(2):185-191. doi: 10.1111/cen.13248. Epub 2016 Oct 21.

Spolaor F, Sawacha Z, Guarneri G, Del Din S, Avogaro A, Cobelli C. Altered EMG patterns in diabetic neuropathic and not neuropathic patients during step ascending and descending. J Electromyogr Kinesiol. 2016 Dec;31:32-39. doi: 10.1016/j.jelekin.2016.08.007. Epub 2016 Aug 20.

Galasso S, Facchinetti A, Bonora BM, Mariano V, Boscari F, Cipponeri E, Maran A, Avogaro A, Fadini GP, Bruttomesso D. Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study. Nutr Metab Cardiovasc Dis. 2016 Dec;26(12):1112-1119. doi:10.1016/j.numecd.2016.08.002. Epub 2016 Aug 6.

Bonora BM, Fadini GP. Subclinical Hypothyroidism and Metabolic Syndrome: A Common Association by Chance or a Cardiovascular Risk Driver? Metab Syndr Relat Disord. 2016 Oct;14(8):378-380. Epub 2016 Aug 23.





- Le complicanze del diabete
- Le malattie cardiovascolari nel paziente diabetico
- Geni della longevità e complicanze del diabete

- Malattie vascolari nel paziente diabetico
- Nefropatia diabetica
- Fattori di rischio cardiovascolari e malattia aterosclerotica nel paziente diabetico